Md. firm’s JV partner gets $7 million S. Korean investment

A Rockville-based pharmaceutical company is expecting to speed up development of an eye drop after its joint venture partner secured $7.28 million in South Korean investments. RegeneRx Biopharmaceuticals Inc. announced Monday that its partner and licensee, G-treeBNT Co. Ltd., will receive $5.92 million from a Korean government investment fund and an additional $1.36 million from a ...

Leave a Reply

Your email address will not be published. Required fields are marked *